Investor Meet Company Q&A Session

Oxford Cannabinoid Technologies Holdings plc, the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market, is pleased to announce the appointment of Axis Capital Markets Limited ("AxCap") as the Company's corporate broker with immediate effect (www.axcap247.com).

AxCap will work alongside OCTP's existing financial adviser, Cairn Financial Advisers LLP.

Investor Meet Company Q&A Session, 4:30 p.m., 30 May 2022

The Company is also pleased to announce that it will be hosting a live online Q&A session via the Investor Meet Company platform at 4:30 p.m. BST on 30 May 2022, which is open to all existing and potential shareholders.

Questions can be submitted pre-event via the 'Investor Meet Company' dashboard up until 9:00 a.m. on Friday 27 May 2022 or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/oxford-cannabinoid-technologies-holdings-plc/register-investor

Investors who already follow OCTP on the Investor Meet Company platform will automatically receive an invitation to the event. The Company will also use this opportunity to respond to questions already received.

The Directors of the Company accept responsibility for the content of this announcement.